private:maryannliebertinc.
|
1385856
|
May 29th, 2019 12:00AM
|
Genetic Engineering & Biotechnology News
|
26K
|
64.00
|
Open
|
Publishing
|
May 29th, 2019 05:22PM
|
May 29th, 2019 05:22PM
|
Genetic Engineering & Biotechnology News (GEN) is the flagship publication of Mary Ann Liebert, Inc. Launched in 1980, GEN was the first publication in this field and remains the key driver in the explosion of the industry, paving the way for the development of new technologies and applications, investment growth, and career opportunities. With 37 years of publishing experience, GEN maintains unrivaled integrity, influence, and expertise that plays a pivotal role in driving the productivity and growth of the industry.
Through its cornerstone Magazine, high-frequency newsletters, and dynamic suite of multimedia resources, GEN is the 360-degree resource that researchers and executives depend on for information that is pivotal for their organization’s success.
GEN’s breadth of editorial coverage is unrivaled in the industry, providing exclusive coverage of the entire bioproduct lifecycle across five key pillars: Drug Discovery, Bioprocessing, OMICS, Translational Medicine, and Gene Editing.
Within these areas, GEN delivers critical, high-quality reporting on the latest industry news; insider information on emerging tools and products; industry-standard tutorials and technical articles on assays, drug discovery, sequencing, genome editing, immunotherapy, and bioprocessing; a first look at emerging industry collaborations; on-site reports from key scientific and industry meetings; and The Lists, our exclusive monthly roundups of top companies, products, and movers & shakers impacting the industry today.
http://www.facebook.com/gennews
https://twitter.com/GENbio
Get Your Free GEN Subscription: https://geneng.omeda.com/gen/index.do?p=GENLI16
|
Open
|
Biotechnology, Drug Discovery, Bioprocessing, Translational Medicine, OMICS, Genome Editing
|
Open
|
140 Huguenot St
|
New Rochelle
|
New York
|
US
|
10801
|
|
Mary Ann Liebert, Inc.
|
|
Pharmaceuticals & Biotechnology
|
private:maryannliebertinc.
|
93104
|
May 29th, 2019 12:00AM
|
Mary Ann Liebert, Inc.
|
2.0K
|
175.00
|
Open
|
Publishing
|
May 29th, 2019 05:23PM
|
May 29th, 2019 05:23PM
|
Mary Ann Liebert, Inc. is a leading independent publisher known worldwide for its prescience and establishment of authoritative peer-reviewed journals, books, and trade publications in cutting-edge fields such as biotechnology, biomedical research, clinical medicine and surgery, public health, technology and engineering, law, environmental policy, and other specialized disciplines. The company publishes over 90 peer-reviewed journals, leading trade magazines, and specialized newsletters, in addition to society membership management and conferences. Mary Ann Liebert Inc. was founded in 1980 and is based in New Rochelle, New York.
|
Open
|
STM Publishing & Peer Reviewed Journals, Biomedical research & life sciences, Clinical medicine and surgery, Alternative & complementary medicine, Election, Environmental & Other Legal Issues, Philanthropy & Planned Giving, Environmental Science & Sustainability
|
Open
|
140 Huguenot Street, 3rd Floor
|
New Rochelle
|
New York
|
US
|
10801-5215
|
|
Mary Ann Liebert, Inc.
|
|
Pharmaceuticals & Biotechnology
|
private:maryannliebertinc.
|
1385856
|
Mar 15th, 2018 12:00AM
|
Genetic Engineering & Biotechnology News
|
10K
|
54.00
|
Open
|
Publishing
|
Mar 14th, 2018 08:29PM
|
Mar 14th, 2018 08:29PM
|
|
Open
|
|
|
|
|
|
|
|
|
Mary Ann Liebert, Inc.
|
|
Pharmaceuticals & Biotechnology
|
private:maryannliebertinc.
|
1385856
|
Feb 17th, 2018 12:00AM
|
Genetic Engineering & Biotechnology News
|
8.4K
|
54.00
|
Open
|
Publishing
|
Feb 17th, 2018 02:25PM
|
Feb 17th, 2018 02:25PM
|
Genetic Engineering & Biotechnology News (GEN) has retained its position as the number one biotech publisher around the globe since its launch in 1981. GEN publishes a print edition 21 times a year and has additional exclusive editorial content online, like news and analysis as well as blogs, podcasts, webinars, polls, videos, and application notes. GEN's unique news and technology focus includes the entire bioproduct life cycle from early-stage R&D, to applied research including omics, biomarkers, as well as diagnostics, to bioprocessing and commercialization.
http://www.facebook.com/gennews
https://twitter.com/GENbio
Get Your Free GEN Subscription: https://geneng.omeda.com/gen/index.do?p=GENLI16
|
|
|
|
|
|
|
|
|
|
Mary Ann Liebert, Inc.
|
|
Pharmaceuticals & Biotechnology
|
private:maryannliebertinc.
|
93104
|
Feb 17th, 2018 12:00AM
|
Mary Ann Liebert, Inc.
|
1.4K
|
155.00
|
Open
|
Publishing
|
Feb 17th, 2018 02:25PM
|
Feb 17th, 2018 02:25PM
|
Mary Ann Liebert, Inc. publishes print and online peer-reviewed journals and books on biotechnology, biomedical research/life sciences, clinical medicine and surgery, alternative and complementary medicine, law, philanthropy, environmental science and sustainability, and engineering. The company’s products include Genetic Engineering & Biotechnology News, Human Gene Therapy, and Journal of Women’s Health, among many others. Mary Ann Liebert Inc. was founded in 1980 and is based in New Rochelle, New York.
|
|
|
|
|
|
|
|
|
|
Mary Ann Liebert, Inc.
|
|
Pharmaceuticals & Biotechnology
|
private:maryannliebertinc.
|
93104
|
Feb 16th, 2018 12:00AM
|
Mary Ann Liebert, Inc.
|
1.4K
|
155.00
|
Open
|
Publishing
|
Feb 16th, 2017 08:15AM
|
Feb 16th, 2017 08:15AM
|
Mary Ann Liebert, Inc. publishes print and online peer-reviewed journals and books on biotechnology, biomedical research/life sciences, clinical medicine and surgery, alternative and complementary medicine, law, philanthropy, environmental science and sustainability, and engineering. The company’s products include Genetic Engineering & Biotechnology News, Human Gene Therapy, and Journal of Women’s Health, among many others. Mary Ann Liebert Inc. was founded in 1980 and is based in New Rochelle, New York.
|
|
|
|
|
|
|
|
|
|
Mary Ann Liebert, Inc.
|
|
Pharmaceuticals & Biotechnology
|
private:maryannliebertinc.
|
1385856
|
Feb 16th, 2018 12:00AM
|
Genetic Engineering & Biotechnology News
|
8.4K
|
54.00
|
Open
|
Publishing
|
Feb 16th, 2017 08:15AM
|
Feb 16th, 2017 08:15AM
|
Genetic Engineering & Biotechnology News (GEN) has retained its position as the number one biotech publisher around the globe since its launch in 1981. GEN publishes a print edition 21 times a year and has additional exclusive editorial content online, like news and analysis as well as blogs, podcasts, webinars, polls, videos, and application notes. GEN's unique news and technology focus includes the entire bioproduct life cycle from early-stage R&D, to applied research including omics, biomarkers, as well as diagnostics, to bioprocessing and commercialization.
http://www.facebook.com/gennews
https://twitter.com/GENbio
Get Your Free GEN Subscription: https://geneng.omeda.com/gen/index.do?p=GENLI16
|
|
|
|
|
|
|
|
|
|
Mary Ann Liebert, Inc.
|
|
Pharmaceuticals & Biotechnology
|
private:maryannliebertinc.
|
93104
|
Feb 15th, 2018 12:00AM
|
Mary Ann Liebert, Inc.
|
1.4K
|
155.00
|
Open
|
Publishing
|
Feb 15th, 2017 10:07AM
|
Feb 15th, 2017 10:07AM
|
Mary Ann Liebert, Inc. publishes print and online peer-reviewed journals and books on biotechnology, biomedical research/life sciences, clinical medicine and surgery, alternative and complementary medicine, law, philanthropy, environmental science and sustainability, and engineering. The company’s products include Genetic Engineering & Biotechnology News, Human Gene Therapy, and Journal of Women’s Health, among many others. Mary Ann Liebert Inc. was founded in 1980 and is based in New Rochelle, New York.
|
|
|
|
|
|
|
|
|
|
Mary Ann Liebert, Inc.
|
|
Pharmaceuticals & Biotechnology
|
private:maryannliebertinc.
|
1385856
|
Feb 15th, 2018 12:00AM
|
Genetic Engineering & Biotechnology News
|
8.4K
|
54.00
|
Open
|
Publishing
|
Feb 15th, 2017 10:07AM
|
Feb 15th, 2017 10:07AM
|
Genetic Engineering & Biotechnology News (GEN) has retained its position as the number one biotech publisher around the globe since its launch in 1981. GEN publishes a print edition 21 times a year and has additional exclusive editorial content online, like news and analysis as well as blogs, podcasts, webinars, polls, videos, and application notes. GEN's unique news and technology focus includes the entire bioproduct life cycle from early-stage R&D, to applied research including omics, biomarkers, as well as diagnostics, to bioprocessing and commercialization.
http://www.facebook.com/gennews
https://twitter.com/GENbio
Get Your Free GEN Subscription: https://geneng.omeda.com/gen/index.do?p=GENLI16
|
|
|
|
|
|
|
|
|
|
Mary Ann Liebert, Inc.
|
|
Pharmaceuticals & Biotechnology
|
private:maryannliebertinc.
|
1385856
|
Feb 14th, 2018 12:00AM
|
Genetic Engineering & Biotechnology News
|
8.4K
|
54.00
|
Open
|
Publishing
|
Feb 14th, 2017 01:50PM
|
Feb 14th, 2017 01:50PM
|
Genetic Engineering & Biotechnology News (GEN) has retained its position as the number one biotech publisher around the globe since its launch in 1981. GEN publishes a print edition 21 times a year and has additional exclusive editorial content online, like news and analysis as well as blogs, podcasts, webinars, polls, videos, and application notes. GEN's unique news and technology focus includes the entire bioproduct life cycle from early-stage R&D, to applied research including omics, biomarkers, as well as diagnostics, to bioprocessing and commercialization.
http://www.facebook.com/gennews
https://twitter.com/GENbio
Get Your Free GEN Subscription: https://geneng.omeda.com/gen/index.do?p=GENLI16
|
|
|
|
|
|
|
|
|
|
Mary Ann Liebert, Inc.
|
|
Pharmaceuticals & Biotechnology
|